SCHEMBL25663164

SCHEMBL25663164

c1ccc2oc(-c3ccc(N(c4ccc(-c5nc6ccccc6o5)cc4)c4ccc(-c5ncnc6c5sc5ccccc56)cc4)cc3)nc2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 8/20 0.41
▸ RAB9A P51151 7/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ ATM Q13315 1/20 0.41
▸ LIMK1 P53667 1/20 0.40
▸ CDK5 Q00535 1/20 0.40
▸ CDK5R1 Q15078 1/20 0.40
▸ KDM4E B2RXH2 5/20 0.39
▸ ALDH1A1 P00352 5/20 0.39
▸ HPGD P15428 5/20 0.39
▸ SMN1; SMN2 Q16637 5/20 0.39
▸ MAPT P10636 4/20 0.39
▸ TP53 P04637 3/20 0.39
▸ LMNA P02545 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ NFKB1 P19838 1/20 0.39
▸ STAT1 P42224 1/20 0.39
▸ GFER P55789 1/20 0.39
▸ NFKB2 Q00653 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25663131 0.87 TLR5 (0.42) NPC1RAB9AMEN1KMT2AATM
SCHEMBL25663122 0.84 NPC1 (0.41) NPC1RAB9AMEN1KMT2AATM
SCHEMBL25663166 0.81 APP (0.50) NPC1RAB9AMEN1KMT2ALIMK1
SCHEMBL25663168 0.80 LIMK1 (0.43) LIMK1CDK5CDK5R1PIK3CA
SCHEMBL24156090 0.79 NPC1 (0.47) NPC1RAB9AMEN1KMT2AATM
SCHEMBL24155749 0.79 NPC1 (0.47) NPC1RAB9AMEN1KMT2AATM
SCHEMBL23328460 0.79 NPC1 (0.44) NPC1RAB9AMEN1KMT2AATM
SCHEMBL25663180 0.78 NPC1 (0.42) NPC1RAB9AMEN1KMT2AATM
SCHEMBL23328462 0.78 NPC1 (0.45) NPC1RAB9AMEN1KMT2AATM
SCHEMBL22791711 0.77 NPC1 (0.47) NPC1RAB9AMEN1KMT2AATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230172057-A1 HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND OPTOELECTRONIC DEVICE WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) 2023-06-01 — — US disclosed
US-20230172057-A1 HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND OPTOELECTRONIC DEVICE WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) 2023-06-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230172057-A1 HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND OPTOELECTRONIC DEVICE CHRM1, CHRM2, CHRM4 NPC1 3859/4885RAB9A 2198/4885MEN1 1967/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback